Xiangling Wang, MD, PHD | |
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
(216) 444-9249 | |
Not Available |
Full Name | Xiangling Wang |
---|---|
Gender | Female |
Speciality | Nephrology |
Experience | 24 Years |
Location | 9500 Euclid Ave, Cleveland, Ohio |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366889438 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 35.134808 (Ohio) | Secondary |
207SG0201X | Medical Genetics - Clinical Genetics (m.d.) | 35.134808 (Ohio) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Much of the Democratic Party's vast reservoir of condescension is currently focused on women, who are urged not to trouble their pretty little heads about actual problems but instead to worry that, 52 years after birth control pills went on the market and 47 years after access to contraception became a constitutional right, reproductive freedom is at risk. This insult may explain the shift of women toward Romney.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
Transplantation of hematopoietic stem cells (HSCs, the cells that can give rise to all blood and most immune cell types) can save patients whose own hematopoietic system is defective or has been destroyed (often through radiation or chemotherapy of cancer).
The Washington Post reports on how the challenges surrounding the implementation of the overhaul are leading Senate candidates in Virginia to some nuanced positions. Meanwhile, Kaiser Health News tracked weekend news coverage of statement by House Minority Leader Nancy Pelosi on why she thinks the GOP position on Medicare will help Democrats take back the House.
The results of an innovative "infectivity" study conducted by the Drugs for Neglected Diseases initiative and the International Centre for Diarrhoeal Disease Research, Bangladesh confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known as post-kala-azar dermal leishmaniasis.
› Verified 5 days ago
Entity Name | The Cleveland Clinic Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Much of the Democratic Party's vast reservoir of condescension is currently focused on women, who are urged not to trouble their pretty little heads about actual problems but instead to worry that, 52 years after birth control pills went on the market and 47 years after access to contraception became a constitutional right, reproductive freedom is at risk. This insult may explain the shift of women toward Romney.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
Transplantation of hematopoietic stem cells (HSCs, the cells that can give rise to all blood and most immune cell types) can save patients whose own hematopoietic system is defective or has been destroyed (often through radiation or chemotherapy of cancer).
The Washington Post reports on how the challenges surrounding the implementation of the overhaul are leading Senate candidates in Virginia to some nuanced positions. Meanwhile, Kaiser Health News tracked weekend news coverage of statement by House Minority Leader Nancy Pelosi on why she thinks the GOP position on Medicare will help Democrats take back the House.
The results of an innovative "infectivity" study conducted by the Drugs for Neglected Diseases initiative and the International Centre for Diarrhoeal Disease Research, Bangladesh confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known as post-kala-azar dermal leishmaniasis.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Xiangling Wang, MD, PHD 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (216) 444-9249 | Xiangling Wang, MD, PHD 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (216) 444-9249 |
News Archive
Much of the Democratic Party's vast reservoir of condescension is currently focused on women, who are urged not to trouble their pretty little heads about actual problems but instead to worry that, 52 years after birth control pills went on the market and 47 years after access to contraception became a constitutional right, reproductive freedom is at risk. This insult may explain the shift of women toward Romney.
Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.
Transplantation of hematopoietic stem cells (HSCs, the cells that can give rise to all blood and most immune cell types) can save patients whose own hematopoietic system is defective or has been destroyed (often through radiation or chemotherapy of cancer).
The Washington Post reports on how the challenges surrounding the implementation of the overhaul are leading Senate candidates in Virginia to some nuanced positions. Meanwhile, Kaiser Health News tracked weekend news coverage of statement by House Minority Leader Nancy Pelosi on why she thinks the GOP position on Medicare will help Democrats take back the House.
The results of an innovative "infectivity" study conducted by the Drugs for Neglected Diseases initiative and the International Centre for Diarrhoeal Disease Research, Bangladesh confirm that people successfully treated for visceral leishmaniasis in South Asia can still infect others if they develop a skin condition known as post-kala-azar dermal leishmaniasis.
› Verified 5 days ago